Treatment for liver metastases typically aims to alleviate symptoms and increase life expectancy. In most cases, there is no way to cure liver metastases.

Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...

Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...

The cancer charity Planets is leading the campaign for the treatment, known as selective internal radiation therapy, to be made available on the NHS.

Each year, it is estimated more than 40,000 people will be diagnosed with liver cancer – and those numbers are increasing.

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

Exelixis stock shines with 36% CABOMETYX sales growth, promising zanzalintinib market expansions, and raised 2025 guidance.

The combination of cabozantinib and atezolizumab appeared more effective than switching ARPI therapy in patients with mCRPC and extrapelvic soft-tissue metastases.

Compared with colorectal cancer (CRC) presenting as an isolated primary or second primary malignancy, CRC presenting as the ...

Adjuvant aspirin did not reduce recurrence or improve survival in patients with CRC liver metastases, phase 3 data showed at ...

Hepatocellular carcinoma (HCC), the most common type of liver cancer and the third-leading cause of cancer-related deaths ...

Cancer is a disease where abnormal cells grow uncontrollably and can invade other parts of the body. One of the most ...